TY  - JOUR
AU  - Mora-Ortiz, Marina
AU  - Alcala-Diaz, Juan F
AU  - Rangel-Zuñiga, Oriol Alberto
AU  - Arenas-de Larriva, Antonio Pablo
AU  - Abollo-Jimenez, Fernando
AU  - Luque-Cordoba, Diego
AU  - Priego-Capote, Feliciano
AU  - Malagon, Maria M
AU  - Delgado-Lista, Javier
AU  - Ordovas, Jose M
AU  - Perez-Martinez, Pablo
AU  - Camargo, Antonio
AU  - Lopez-Miranda, Jose
PY  - 2022
DO  - 10.1186/s12916-022-02566-z
UR  - http://hdl.handle.net/10668/20310
T2  - BMC medicine
AB  - Type 2 diabetes mellitus (T2DM) is one of the most widely spread diseases, affecting around 90% of the patients with diabetes. Metabolomics has proven useful in diabetes research discovering new biomarkers to assist in therapeutical studies and...
LA  - en
PB  - BioMed Central
KW  - Diabetes
KW  - Insulin resistance
KW  - Metabolomics
KW  - Prospective human study
KW  - Humans
KW  - Biomarkers
KW  - Diabetes mellitus, type 2
KW  - Discriminant analysis
KW  - Metabolomics
KW  - ROC Curve
TI  - Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study.
TY  - Research article
VL  - 20
ER  -